European Archives - Page 390 of 1209 - European Medical Journal

AZ’s Stefan Woxström on preparing healthcare systems for the future

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.

Stable Mortality Rates Despite Rising Incidence of Melanoma

Mortality rates of Melanoma have remained stable despite rising incidence, with reasons for this disparity still unclear.

Higher Prevalence of Functional Disability in Survivors of Cancer

New findings from a USA telephone survey found that more than one-quarter of cancer survivors reported mobility disability, while close to 10% reported self-care disability

Prenatal Bisphenol and Phthalate Exposure Impact on Child Adiposity

A study aimed to understand how exposure to endocrine-disrupting chemicals impacts early childhood growth.

Prenatal Cannabis and Nicotine Use Linked to Adverse Outcomes

Concurrent prenatal cannabis and nicotine use has been linked to adverse maternal and neonatal outcomes.

CALIPSO Trial: Breaking News from EuroPCR

The CALIPSO trial has unveiled evidence supporting the use of optical coherence tomography in guiding percutaneous coronary intervention for moderate to severe calcified lesions.

DOCTORS-LM Trial: Breaking News from EuroPCR 2024

A recent randomised open-label trial reveals important findings on the efficacy of optical coherence tomography in guiding angioplasty for left main coronary artery lesions.

GSK pledges £45m to new antimicrobial resistance initiative

GSK has pledged £45m to the Fleming Initiative, a UK scheme to tackle antimicrobial resistance, led by Imperial College Healthcare NHS Trust and Imperial College London.

Suppressive Antibiotics for Joint Infections: Benefit Debate Unveiled

Benefits of suppressive antibiotic therapy (SAT) may be limited, according to new research

New Study Challenges 'Shorter is Better' in Antibiotic Treatment

Shorter courses of antibiotics have been associated with increased risk of reinfection and death when used to treat infants for E. coli bacteraemia, a new study has shown